Search company, investor...

Founded Year

1999

Stage

Acquired | Acquired

Total Raised

$7.75M

About Invistics

Invistics develops and provides cloud-based software solutions and supporting consulting services. It offers drug diversion detection and controlled substance compliance. The company was founded in 1999 and is based in Peachtree Corners, Georgia. In June 2023, Invistics was acquired by Wolters Kluwer Health. The terms of the transaction were not disclosed.

Headquarters Location

5155 Peachtree Parkway Suite 3200

Peachtree Corners, Georgia, 30092,

United States

800-601-3456

Loading...

Loading...

Invistics Patents

Invistics has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/6/2006

3/3/2009

Supply chain management, Distribution (business), Inventory, Manufacturing, Production and manufacturing

Grant

Application Date

3/6/2006

Grant Date

3/3/2009

Title

Related Topics

Supply chain management, Distribution (business), Inventory, Manufacturing, Production and manufacturing

Status

Grant

Latest Invistics News

Wolters Kluwer Health Acquires AI Drug Diversion Detection Company Invistics

Jun 15, 2023

What You Should Know: Wolters Kluwer Health today announced the acquisition of  Invistics Corporation  (Invistics), a U.S.-based provider of cloud-based, AI-enabled software for drug diversion detection and controlled substance compliance. Invistics will join the company’s Clinical Surveillance, Compliance & Data Solutions unit, part of Clinical Solutions. Financial details of the acquisition were not disclosed. Invistics’ solution, Flowlytics, uses predictive analytics to detect illicit diversion of both controlled and non-controlled medications in patient care settings such as hospitals and ambulatory surgery centers. Flowlytics reconciles drug transactions from purchase to patient and uses AI to rapidly and accurately identify patterns of behavior consistent with drug diversion. Impact of Drug Diversion Drug diversion is a growing challenge in the U.S. healthcare system, costing some $70 billion per year. One study estimates 10% to 15% of health professionals will misuse drugs or alcohol at some point in their career, increasing the risk for drug diversion.¹ Drug diversion occurs when a healthcare worker illegally obtains or uses prescription drugs intended for a patient. A five-year National Institutes of Health-funded study found that Flowlytics detected cases of drug diversion faster and with more efficiency than legacy solutions.² In addition to detection, the solution also supports diversion investigation, adjudication, and reporting workflows. Acquisition Impact Wolters Kluwer Health expects the acquisition to deliver a return on invested capital (ROIC) above its weighted average cost of capital (8%) within 3-5 years and expects the transaction to have an immaterial impact on adjusted earnings. Invistics will join the company’s Clinical Surveillance, Compliance & Data Solutions unit, part of Clinical Solutions.

Invistics Frequently Asked Questions (FAQ)

  • When was Invistics founded?

    Invistics was founded in 1999.

  • Where is Invistics's headquarters?

    Invistics's headquarters is located at 5155 Peachtree Parkway, Peachtree Corners.

  • What is Invistics's latest funding round?

    Invistics's latest funding round is Acquired.

  • How much did Invistics raise?

    Invistics raised a total of $7.75M.

  • Who are the investors of Invistics?

    Investors of Invistics include Wolters Kluwer Health, Paycheck Protection Program, H.I.G. Ventures, InterSouth Partners, Imlay Investments and 4 more.

  • Who are Invistics's competitors?

    Competitors of Invistics include ThroughPut, Mojix, LeanDNA, Vekia, Adello Biologics and 7 more.

Loading...

Compare Invistics to Competitors

A
AviServe

AviServe aims to provide an accurate, contemporary, responsive and science based resource laboratory and consulting service for use by the poultry and allied industries. The company aims to assist clients with the recognition and control of conventional and complex diseases that affect the profitability of the poultry, biologics, diagnostics and animal pharmaceuticals industries. Per the company, they have the ability to develop disease diagnostics and control strategies that can be individualized on a company or geographical basis.

A
Axis Pharmaceutical Packaging

Axis Pharmaceutical Packaging has developed a high-quality, high-speed, pharmaceutical solid dose medication bottle filling machine that meets industry and FDA standards.

S
Stat Analysis

Stat Analysis, also known as Sterling Labs, specializes in environmental and industrial hygiene testing within the environmental laboratory industry. The company offers a broad range of services including environmental testing, PFAS and specialty services, industrial hygiene, asbestos testing, and product safety evaluations. Sterling Labs serves engineering firms, environmental consultants, industrial manufacturers, and federal agencies, providing accurate and timely analytical results to support their projects. It is based in Chicago, Illinois.

S
Supercritical Fluid Technologies

Supercritical Fluid Technologies Inc. specializes in providing innovative solutions for separation and material processing needs within the technology sector. The company offers cutting-edge equipment and custom solutions designed to facilitate high-quality separations and processing for various applications. It was founded in 1994 and is based in Newark, Delaware.

S
STEMGEN SPA

STEMGEN SPA is a clinical stage biotech company focused on developing innovative differentiation biotherapies for cancer within the biotechnology and healthcare industry. The company's main service is a differentiation therapy that aims to transform cancer stem cells into mature brain cells, offering a novel approach to treating solid tissue cancers. This therapy is particularly targeted at addressing glioblastoma multiforme, a highly aggressive and incurable brain tumor. It is based in Italy.

ImmunoReagents Logo
ImmunoReagents

ImmunoReagents is a manufacturer of antibodies and reagents for the pharmaceutical, biotechnology, life science research, and in vitro diagnostics industries. The company offers a range of products including primary and secondary antibodies, ELISA and Western Blot reagents, and antibody purification tools. ImmunoReagents also provides bulk immunoassay reagents and OEM services for the production of research reagents and diagnostic immunoassays. It was founded in 2005 and is based in Raleigh, North Carolina.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.